UNSPSC 51413503: Nicotinyl alcohol or pyridylcarbinol

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9TF312056Y. European Medicines Agency schedules Nicotinyl alcohol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14650MIG. Nicotinyl alcohol generally arises in the molecular formula C6H7NO. The term 'nicotinyl alcohol' is a United States Adopted Name designation. SMILES: C1=CC(=CN=C1)CO.

UNSPSC 51413503 Nicotinyl alcohol or pyridylcarbinol is a Commodity code covering pharmaceutical and chemical compounds procured by state and local governments for medical, therapeutic, and emergency response applications. State and local bodies are actually buying emergency medications, generic pharmaceuticals, and over-the-counter products through this code — not the narrow chemical compound alone suggested by the code name. Issuing bodies include municipal fire and rescue departments (Tampa Fire Rescue through the City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The code sees activity across municipal procurement offices, state pharmacy benefit programs, and regional purchasing consortia that aggregate demand for multiple jurisdictions.

Recent activity concentrates in Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26P00188) on April 24, 2026, due April 8, 2026, for Advanced Life Support Medications including 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000.00 and a one-year term plus renewal options. The Texas HHS Commission issued an RFI (HHS0017013) on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager arrangements. MMCAP, administered by Minnesota Department of Administration, posted an RFP (S1070000015802) on January 20, 2026, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) to participating state and local facilities across Minnesota and Oregon, with a two-year initial term and optional extensions. The Tampa solicitation includes a 5 percent bid discount for Small Local Business Enterprise participation. All suppliers must maintain expiration-date guarantees (nine months or more for Tampa; one year from manufacture plus six-month minimum shelf life for MMCAP), comply with FDA and OSHA requirements, and furnish Safety Data Sheets.